Jyothy Labs schedules Q2FY27 analyst call for November 4, 2026

scanx
Reviewed by
Ashish TScanX News Team
Key Highlights
  • Jyothy Laboratories hosts analyst call on November 4, 2026
  • Event discusses Q2FY27 and H1FY27 financial results
  • ICICI Securities facilitates the conference call access
powered bylight_fuzz_icon
53499909

*this image is generated using AI for illustrative purposes only.

Jyothy Laboratories will host a conference call for analysts and investors on Wednesday, November 4, 2026, at 4:00 pm IST. The session will focus on the company's financial performance for the quarter and half year ended September 30, 2026.

The announcement was made pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The call is scheduled subsequent to the declaration of the company's unaudited financial results for the said period.

Call details and access

ICICI Securities is facilitating the conference call. Participants can join via universal access numbers or toll-free lines from various international locations.

Location Access Number
Universal +91 22 6280 1144; +91 22 7115 8045
Singapore 8001012045
Hong Kong 800964448
UK 08081011573
USA 18667462133

Contact information

For clarifications regarding the event, participants may contact the designated coordinators at ICICI Securities.

  • Mr. Manoj Menon, Head of Research: +91 22 6807 7209
  • Mr. Ashutosh Joytiraditya: +91 22 6807 7632
  • Mr. Rushad Kapadia: +91 22 6807 7334

Additional details are available on the company's website at www.jyothylabs.com .

Historical Stock Returns for Jyothy Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
+1.17%+3.10%-3.11%-13.67%-39.19%+15.92%

How will Jyothy Laboratories' Q2 FY27 revenue growth compare to the recent volume trends in the Indian FMCG sector?

What impact have recent raw material cost fluctuations had on the company's EBITDA margins for the quarter ended September 2026?

Are there any new product launches or category expansions planned that could drive future top-line growth?

Jyothy Labs puts acquisitions on hold, focuses on personal care

scanx
Reviewed by
Naman SScanX News Team
Key Highlights
  • Jyothy Laboratories has put acquisitions on hold, per a newspaper report
  • The company is redirecting focus toward new product launches
  • Personal care segment has been identified as a key area of strategic emphasis
powered bylight_fuzz_icon
52548434

*this image is generated using AI for illustrative purposes only.

Jyothy Laboratories has put acquisitions on hold and is redirecting its strategic focus toward new product launches and the personal care segment, according to a newspaper report.

Strategic shift in focus

The company's decision to pause inorganic growth activity signals a pivot toward building its existing portfolio organically. The emphasis on personal care and new product development indicates a near-term priority on internal capabilities over external acquisitions.

Strategic parameter Details
Acquisitions status On hold
Focus areas New products, personal care segment

Historical Stock Returns for Jyothy Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
+1.17%+3.10%-3.11%-13.67%-39.19%+15.92%
Disclaimer: This article is AI-generated using data from LiveSquawk. ScanX is not liable for any inaccuracies.

How will the pause in acquisitions impact Jyothy Laboratories' long-term market share strategy against competitors like HUL and Dabur?

What specific product categories within the personal care segment is Jyothy prioritizing for its upcoming launches?

How might the shift to organic growth affect the company's capital expenditure plans and free cash flow generation in the next fiscal year?

More News on Jyothy Laboratories

1 Year Returns:-39.19%